Exploring Initial Strategies In Advanced Melanoma
If you are looking for information about Initial Strategies In Advanced Melanoma, you have come to the right place.
- Jason Luke, MD, FACP, FASCO, University of Pittsburgh, Pittsburgh, PA, describes the Phase II/III TeLuRide-006 trial ...
- An overview of recent trials exploring adjuvant and neoadjuvant
- Panelists Robert H.I. Andtbacka, MD, CM; Georgina Long, MD; and Antoni Ribas, MD, PhD, provide insight on the potential for ...
- Groundbreaking science leads to new dual immunotherapy treatment for
- Panelists Keith T. Flaherty, MD; Jason J. Luke, MD; Georgina Long, BSc, MBBS; and Jeffrey S. Weber, MD, provide insight on the ...
In-Depth Information on Initial Strategies In Advanced Melanoma
Panelists Keith T. Flaherty, MD; Jonathan S. Zager, MD; and Georgina Long, BSc, MBBS, FRACP, consider the options for ... Michael B. Atkins, MD, and Michael A. Postow, MD, describe the factors they consider in their Hussein A. Tawbi, MD, PhD, highlights treatment Presentation given by Lance Cowey, MD, as part of the AIM at
Presentation given by Lance Cowey, MD, at Baylor Charles A. Sammons Cancer Center, as part of AIM at
We hope this detailed breakdown of Initial Strategies In Advanced Melanoma was helpful.
